Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin
Launched by FEDERAL TEACHING HOSPITAL ABAKALIKI · Apr 29, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a medication called Propranolol on the time it takes for labor to progress when using another medication called oxytocin to induce labor. Inducing labor is sometimes necessary to ensure a safe delivery, but it can lead to longer labor times, which may cause complications for both the mother and the baby. The researchers want to see if taking Propranolol can help speed up the delivery process and make it easier for women who are being induced.
To participate in this trial, women must be pregnant with a single baby in the right position for delivery. However, some women will not be eligible, such as those who have certain medical conditions, are on beta blockers, or have experienced complications like preterm labor or bleeding. The trial is not yet recruiting participants, but once it starts, those who qualify will be closely monitored to see how Propranolol affects their labor experience. This study aims to provide more information about Propranolol's role in improving labor outcomes for women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • singleton foetus
- • cephalic presentation at term
- Exclusion Criteria:
- • Patients on beta blockers
- • Contraindications to labour or vaginal delivery
- • Multiple gestations
- • Preterm labour
- • Chorioamnionitis
- • Known fetal anomalies
- • Bronchial asthma
- • Abnormal fetal presentation.
- • Antepartum haemorrhage.
- • Lung disease
- • Previous uterine scar or surgery.
- • Foetal heart irregularity
About Federal Teaching Hospital Abakaliki
Federal Teaching Hospital Abakaliki is a leading healthcare institution dedicated to providing comprehensive medical services, education, and research. As a clinical trial sponsor, the hospital is committed to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on ethical practices and patient safety, the hospital collaborates with various stakeholders to conduct clinical trials that address pressing health challenges. Its multidisciplinary team of healthcare professionals and researchers leverages state-of-the-art facilities to facilitate groundbreaking studies, ultimately contributing to the enhancement of evidence-based medicine and public health outcomes in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abakaliki, Ebonyi, Nigeria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported